BORTEZOMIB
Generic: BORTEZOMIB
Eugia US LLCManufacturer
INTRAVENOUS, SUBCUTANEOUSRoute
BORTEZOMIBActive Substance
2022-05-02Original Approval
BORTEZOMIB is FDA application ANDA212825, sponsored by EUGIA PHARMA. Any recalls listed below come from FDA drug enforcement reports, and reaction counts are the number of FAERS adverse event reports that mention the drug and that reaction; a report does not prove the drug caused it.
Top Reported Reactions
1
PLASMA CELL MYELOMA
5,197 reports
2
OFF LABEL USE
3,199 reports
3
DRUG INEFFECTIVE
2,262 reports
4
NEUROPATHY PERIPHERAL
1,867 reports
5
THROMBOCYTOPENIA
1,764 reports
6
DEATH
1,576 reports
7
PNEUMONIA
1,546 reports
8
NEUTROPENIA
1,407 reports
9
DIARRHOEA
1,379 reports
10
FATIGUE
1,143 reports